• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Vertex Pharmaceuticals

Paragliding over the cliffs Fort Funston San Francisco
Biotech

Altos ascends with new clinical leader—Chutes & Ladders

Altos ascends with new clinical leader. Vertex vet set to retire. Keros shakes up C-suite to go all in on DMD.
Darren Incorvaia , Gabrielle Masson Aug 8, 2025 8:30am
dart board miss failure

Vertex drops asset in acute pain after phase 2 fail

Aug 4, 2025 5:34pm
Small white blocks with black text that say Diabetes Type 1 in all caps surrounded by syringes containing a blue liquid th

Vertex diabetes islet cell therapy improves blood sugar levels

Jun 23, 2025 4:21am
layoffs

Vertex consolidates Rhode Island footprint, cuts 125 jobs

Jun 11, 2025 10:38am
Illustration connected puzzle pieces with the acronym MA

Lilly lands next-gen pain asset in $1B SiteOne acquisition

May 27, 2025 11:30am
pause button on blue background

Vertex takes $379M hit tied to cancelled islet cell program

May 6, 2025 12:50pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings